TNFα blockade for inflammatory rheumatic diseases is associated with a significant gain in android fat mass and has varying effects on adipokines: a 2-year prospective study.
about
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique backgroundRelationships between Adipose Tissue and Psoriasis, with or without ArthritisRheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis.Effects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis.Angiopoietin-like 4: A molecular link between insulin resistance and rheumatoid arthritis.Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis.Compensatory anabolic signaling in the sarcopenia of experimental chronic arthritis.Can Creatine Supplementation Improve Body Composition and Objective Physical Function in Rheumatoid Arthritis Patients? A Randomized Controlled Trial.Paradoxical elevation of serum TRACP5b levels despite increase in lumbar spine bone mineral density during anti-TNFα therapy in patients with inflammatory rheumatic disease: a 2-year prospective assessment of bone mass, bone metabolism, and the trabDistinct Secretory Activity and Clinical Impact of Subcutaneous Abdominal Adipose Tissue in Women with Rheumatoid Arthritis and Osteoarthritis.Resistin Gene Expression is Downregulated in CD4(+) T Helper Lymphocytes and CD14(+) Monocytes in Rheumatoid Arthritis Responding to TNF-α Inhibition.
P2860
Q26765175-3A6E875C-5078-4D1F-B832-EBAE07613A33Q27025534-FEE82185-B375-4C28-8B60-8909CE1273F9Q35596467-3495BFD2-FA0C-461B-A4A9-659FDC825735Q38323310-1E99AC74-21B4-45AD-87C9-10391DBF6C85Q39048436-54A3A36C-A4BD-4BCC-8899-3A1F3C35E767Q39993473-E27033D5-FFBF-4216-8F79-3718063EA1C7Q40109875-E147EAC3-106E-4AEB-B19D-23FF152BE308Q40491482-ED0CBDBB-6C3B-4BDB-B403-CE3CC569F600Q45832844-2F90CEA5-C94C-4A39-9F51-6AB2ABA63A7AQ51354466-50FCB221-CA80-498E-ADFC-68440EC4E448Q51630863-878A4D06-CBBB-4705-95F4-248D035CFFF5
P2860
TNFα blockade for inflammatory rheumatic diseases is associated with a significant gain in android fat mass and has varying effects on adipokines: a 2-year prospective study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
TNFα blockade for inflammatory ...... s: a 2-year prospective study.
@en
TNFα blockade for inflammatory ...... s: a 2-year prospective study.
@nl
type
label
TNFα blockade for inflammatory ...... s: a 2-year prospective study.
@en
TNFα blockade for inflammatory ...... s: a 2-year prospective study.
@nl
prefLabel
TNFα blockade for inflammatory ...... s: a 2-year prospective study.
@en
TNFα blockade for inflammatory ...... s: a 2-year prospective study.
@nl
P2093
P2860
P1476
TNFα blockade for inflammatory ...... s: a 2-year prospective study.
@en
P2093
Barbara Dehecq
Gilles Dumoulin
Émilie Grandclément
Éric Toussirot
P2860
P2888
P304
P356
10.1007/S00394-013-0599-2
P577
2013-10-31T00:00:00Z